Cost-Utility Comparison of Down-Titration Strategies for Safer and More Efficient Use of Biologics in Adults with Rheumatoid Arthritis and Psoriatic Arthritis

  • March, Lyn (PI)
  • Tymms, Kathleen (PI)
  • Buchbinder, Rachelle (CoI)
  • Hill, Catherine (CoI)
  • Keen, Helen (CoI)
  • Lassere, Marissa Nichole (CoI)
  • Perera, Chandima (CoI)
  • Proudman, Susanna M. (CoI)
  • Schofield, Deborah (CoI)
  • Sinnathurai, Premarani (CoI)
  • Thomas, Ranjeny (CoI)
  • Wechalekar, M (CoI)
  • Whittle, Samuel (CoI)
  • Xue, Meilang (CoI)

    Project: Research

    Project Details

    Description

    Aim: Recent systematic reviews (incl. ANZMUSC Living Guidelines) suggest stronger evidence is needed for biologic/biosimilar therapy (bDMARDs) down-titration recommendations in rheumatoid arthritis (RA) and psoriatic arthritis (PsA). This trial aims to identify the optimal down-titration strategies for safer and more efficient biologic use in RA and PsA patients.
    StatusActive
    Effective start/end date1/06/22 → 30/09/26

    Fingerprint

    Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
    View full fingerprint